Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Franks

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Nephron|January 1, 1990
Prospective effect of norepinephrine infusion in acute renal insufficiency induced by interleukin 2 therapyB Allaouchiche, A Mercatello, E Tognet, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancerR L Jansen, R Slingerland, S H Goey, et al.
European Journal of Cancer|September 1, 1975
Metastatic growth of human tumour xenografts in thymectomised irradiated micr reconstituted with syngeneic bone marrow cellsC R Franks, L R Boulger, A J Garrett, et al.
Onkologie|April 1, 1990
Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II studyL Bergmann, E Weidmann, P S Mitrou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
A phase 2 trial of recombinant interleukin-2 and 5-fluorouracil in patients with metastatic colorectal carcinomaI Reid, I Sharpe, W Maxwell, et al.
Therapeutic Drug Monitoring|September 1, 1987
Comparison of the pharmacokinetics of AMSA and AMSA-lactate in patients with acute nonlymphoblastic leukemiaC Y Paul, J O Liliemark, R H Farmen, et al.
Cancer Research|August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988M C Favrot, C Coze, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Nephron|January 1, 1990
Prospective effect of norepinephrine infusion in acute renal insufficiency induced by interleukin 2 therapyB Allaouchiche, A Mercatello, E Tognet, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Interleukin-2 and interferon-alpha in the treatment of patients with advanced non-small-cell lung cancerR L Jansen, R Slingerland, S H Goey, et al.
European Journal of Cancer|September 1, 1975
Metastatic growth of human tumour xenografts in thymectomised irradiated micr reconstituted with syngeneic bone marrow cellsC R Franks, L R Boulger, A J Garrett, et al.
Onkologie|April 1, 1990
Interleukin-2 in combination with interferon-alpha in disseminated malignant melanoma and advanced renal cell carcinoma. A phase I/II studyL Bergmann, E Weidmann, P S Mitrou, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 1, 1992
A phase 2 trial of recombinant interleukin-2 and 5-fluorouracil in patients with metastatic colorectal carcinomaI Reid, I Sharpe, W Maxwell, et al.
Therapeutic Drug Monitoring|September 1, 1987
Comparison of the pharmacokinetics of AMSA and AMSA-lactate in patients with acute nonlymphoblastic leukemiaC Y Paul, J O Liliemark, R H Farmen, et al.
Cancer Research|August 1, 1989
Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988M C Favrot, C Coze, V Combaret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2P A Palmer, J Vinke, T Philip, et al.
European Urology|January 1, 1992
Intravesical therapy of superficial bladder transitional cell carcinoma with tumor necrosis factor-alpha: preliminary report of a phase I-II studyV Serretta, G Corselli, B Piazza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1991
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II studyG Stoter, S Aamdal, S Rodenhuis, et al.
Pageof 10